(Q69735777)

English

Influence of the donors' clinical status on in vitro and in vivo tumor-cytotoxic activation of interleukin-2-exposed lymphocytes and their circulation in different organs

scientific article published on 01 January 1989

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2783888%20AND%20SRC:MED&resulttype=core&format=json

5 October 2019

Influence of the donors' clinical status on in vitro and in vivo tumor-cytotoxic activation of interleukin-2-exposed lymphocytes and their circulation in different organs (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2783888%20AND%20SRC:MED&resulttype=core&format=json

5 October 2019

author name string

M Rodolfo

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2783888%20AND%20SRC:MED&resulttype=core&format=json

5 October 2019

C Salvi

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2783888%20AND%20SRC:MED&resulttype=core&format=json

5 October 2019

G Parmiani

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2783888%20AND%20SRC:MED&resulttype=core&format=json

5 October 2019

publication date

1 January 1989

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2783888%20AND%20SRC:MED&resulttype=core&format=json

5 October 2019

Cancer Immunology, Immunotherapy

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2783888%20AND%20SRC:MED&resulttype=core&format=json

5 October 2019

28

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2783888%20AND%20SRC:MED&resulttype=core&format=json

5 October 2019

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2783888%20AND%20SRC:MED&resulttype=core&format=json

5 October 2019

136-142

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2783888%20AND%20SRC:MED&resulttype=core&format=json

5 October 2019

https://scigraph.springernature.com/pub.10.1007/bf00199114

0 references

In vitro and in vivo antitumor activity of lymphokine-induced cytotoxic cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/2783888

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Establishment of mouse colonic carcinoma cell lines with different metastatic properties

1 reference

https://pubmed.ncbi.nlm.nih.gov/2783888

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Eradication of disseminated murine leukemia by treatment with high-dose interleukin 2

1 reference

https://pubmed.ncbi.nlm.nih.gov/2783888

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunotherapy of cancer using interleukin 2: current status and future prospects

1 reference

https://pubmed.ncbi.nlm.nih.gov/2783888

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vivo localization of cloned IL-2-dependent T cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/2783888

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lymphokine-activated killer cells: a new approach to immunotherapy of cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/2783888

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Changes in the host natural killer cell population in mice during tumor development. 2. The mechanism of suppression of NK activity

1 reference

https://pubmed.ncbi.nlm.nih.gov/2783888

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adoptive Immunotherapy of Established Pulmonary Metastases with LAK Cells and Recombinant Interleukin-2

1 reference

https://pubmed.ncbi.nlm.nih.gov/2783888

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Systemic administration of recombinant human interleukin-2 in mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/2783888

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunoregulation and immunostimulation of murine lymphocytes by recombinant human interleukin-2.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2783888

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interleukin 2 administered in vivo induces the growth of cultured T cells in vivo

1 reference

https://pubmed.ncbi.nlm.nih.gov/2783888

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Circulating T and B lymphocytes of the mouse. I. Migratory properties

1 reference

https://pubmed.ncbi.nlm.nih.gov/2783888

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lysis of primary hepatic tumours by lymphokine activated killer cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/2783888

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical effects and toxicity of interleukin-2 in patients with cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/2783888

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A phase I study of recombinant interleukin 2 in melanoma patients. Toxicity and clinical effects.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2783888

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Constant-infusion recombinant interleukin-2 in adoptive immunotherapy of advanced cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/2783888

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tumor induction relationships in development of transplantable cancers of the colon in mice for chemotherapy assays, with a note on carcinogen structure

1 reference

https://pubmed.ncbi.nlm.nih.gov/2783888

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vivo administration of purified human interleukin 2. II. Half life, immunologic effects, and expansion of peripheral lymphoid cells in vivo with recombinant IL 2.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2783888

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Up- and down-regulation of human lymphokine (IL-2)-activated killer cell induction by monocytes, depending on their functional state.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2783888

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Assessment of in vivo natural antitumor resistance and lymphocyte. Migration in mice: comparison of 125I-iododeoxyuridine with 111indium-oxine and 51chromium as cell labels.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2783888

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antitumor efficacy of lymphokine-activated killer cells and recombinant interleukin-2 in vivo: survival benefit and mechanisms of tumor escape in mice undergoing immunotherapy.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2783888

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Role of interleukin 2 and a serum suppressive factor on the induction of activated killer cells cytotoxic for autologous human melanoma cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/2783888

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunogenicity of chemically induced murine colon cancers

1 reference

https://pubmed.ncbi.nlm.nih.gov/2783888

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recombinant interleukin 2 stimulates in vivo proliferation of adoptively transferred lymphokine-activated killer (LAK) cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/2783888

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Growth inhibition of murine colonic adenocarcinoma by tumor immune but not by IL-2-activated or alloactivated lymphocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/2783888

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone

1 reference

https://pubmed.ncbi.nlm.nih.gov/2783888

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The systemic administration of purified interleukin 2 enhances the ability of sensitized murine lymphocytes to cure a disseminated syngeneic lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/2783888

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adoptive immunotherapy of murine hepatic metastases with lymphokine activated killer (LAK) cells and recombinant interleukin 2 (RIL 2) can mediate the regression of both immunogenic and nonimmunogenic sarcomas and an adenocarcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/2783888

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Systemic administration of recombinant interleukin 2 stimulates in vivo lymphoid cell proliferation in tissues

1 reference

https://pubmed.ncbi.nlm.nih.gov/2783888

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The in vivo distribution of autologous human and murine lymphoid cells grown in T cell growth factor (TCGF): implications for the adoptive immunotherapy of tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/2783888

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunoregulatory T-lymphocyte functions in patients with small cell lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/2783888

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q69735777&oldid=1753484108"